We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Superobesity Associated with Risk of Death Following Bariatric Surgery

By HospiMedica International staff writers
Posted on 03 Nov 2009
Those classified as superobese and those with a higher chronic disease burden appear more likely to die within a year of having bariatric surgery, according to a new study.

Researchers at the University of Washington (Seattle, USA), the University of Colorado (Boulder, USA), the U.S. More...
department of Veterans Affairs (VA; Washington, DC, USA), and other institutions examined patient factors associated with the risk of death among 856 veterans who underwent bariatric surgery in any of 12 VA bariatric centers from 2000 to 2006; the patients had an average body mass index (BMI) of 48.7, an average age of 54 years, and 73% were men. The researchers found that overall, a total of 54 patients (6.3%) died during the follow-up period; 1.3% of the patients died 30 days after surgery, 2.1% died 90 days after surgery, and 3.4% had died after one year. In statistical models performed by the researchers, the patients who were classified as superobese--those having a BMI of 50 or higher, representing 36% of the sample--and those with a higher score on a measure of costs related to co-occurring diseases (8% of the sample) had an increased risk of death. The superobese patients, who accounted for 30 deaths, had 30-day, 90-day, and one-year death rates of 2.0%, 3.6%, and 5.2%, whereas those with a higher comorbidity cost score had rates of 1.5%, 5.8%, and 10.1%, respectively. The study was published in the October 2009 issue of Archives of Surgery.

"The results of this study should inform discussions with patients with regard to the potential risks and benefits of bariatric surgery,” concluded lead author David Arterburn, M.D., M.P.H., of the University of Washington and the Group Health Research Institute (Seattle, USA), and colleagues. "These findings also suggest that the risks of bariatric surgery in patients with significant comorbidities, such as congestive heart failure, complicated diabetes, and chronic obstructive pulmonary disease, should be carefully weighed against potential benefits in older male patients and those with superobesity.”

Bariatric surgery is one of the few interventions that can help morbidly obese individuals lose enough weight to significantly improve their health and quality of life. However, while the risk of death associated with bariatric surgery is traditionally thought to be low, most previous studies have involved younger women, rather than the older male population that typically uses VA facilities.

Related Links:
University of Washington
University of Colorado
U.S. department of Veterans Affairs
Group Health Research Institute


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.